IBM InfoSphere Information Server up to 8.1 Web Console cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.4 | $0-$5k | 0.00 |
Summary
A vulnerability was found in IBM InfoSphere Information Server up to 8.1. It has been rated as problematic. This issue affects some unknown processing of the component Web Console. The manipulation leads to cross site scripting. This vulnerability is listed as CVE-2013-3034. The attack may be initiated remotely. There is no available exploit.
Details
A vulnerability was found in IBM InfoSphere Information Server up to 8.1 (Reporting Software). It has been rated as problematic. This issue affects an unknown function of the component Web Console. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. The summary by CVE is:
Cross-site scripting (XSS) vulnerability in IBM InfoSphere Information Server through 8.5 FP3, 8.7 through FP2, and 9.1 allows remote authenticated users to inject arbitrary web script or HTML via vectors related to the web console.
The weakness was presented 08/15/2013 (Website). The advisory is shared at www-01.ibm.com. The identification of this vulnerability is CVE-2013-3034 since 04/12/2013. The attack may be initiated remotely. The successful exploitation requires a simple authentication. It demands that the victim is doing some kind of user interaction. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
It is declared as highly functional.
The vulnerability is also documented in the databases at X-Force (84646) and SecurityFocus (BID 61757†). See VDB-64674 and VDB-64672 for similar entries. Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 3.5VulDB Meta Temp Score: 3.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.4
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Highly functional
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
04/12/2013 🔍08/12/2013 🔍
08/15/2013 🔍
08/15/2013 🔍
03/24/2015 🔍
02/28/2018 🔍
Sources
Vendor: ibm.comAdvisory: www-01.ibm.com
Status: Confirmed
Confirmation: 🔍
CVE: CVE-2013-3034 (🔍)
GCVE (CVE): GCVE-0-2013-3034
GCVE (VulDB): GCVE-100-64673
X-Force: 84646 - IBM InfoSphere Information Server HTML cross-site scripting
SecurityFocus: 61757 - IBM InfoSphere Information Server CVE-2013-3034 Unspecified HTML Injection Vulnerability
See also: 🔍
Entry
Created: 03/24/2015 15:54Updated: 02/28/2018 08:06
Changes: 03/24/2015 15:54 (51), 02/28/2018 08:06 (6)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.